Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antigen Presenting Cells01:22

Antigen Presenting Cells

4.3K
The immune system is a complex network of cells and molecules that protects the body from foreign invaders. T cells, a type of white blood cell, play a crucial role in this process. They recognize and attack foreign substances, such as pathogens, that enter the body.
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
4.3K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

28.6K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.6K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

6.3K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Superior Stable NIR-II Emissive Radicals Enabled by a Symmetric Dual-Acceptor Engineering for Immunogenic Sono/Photodynamic Theranostics.

Journal of the American Chemical Society·2026
Same author

Fecal hemoglobin concentration as a risk stratification tool for advanced colorectal neoplasm in a community-based screening program.

Frontiers in oncology·2026
Same author

Composite hydrogels encapsulating soy oleosome-associated protein-modified liposomes: Effects of protein on gel texture and release attribute.

International journal of biological macromolecules·2026
Same author

Citywide community-based colorectal cancer screening in urban Shanghai: age and sex variations in risk mitigation from 1973 to 2020.

Frontiers in oncology·2025
Same author

Air-dried high-strength black MXene aerogel for spatiotemporal infrared information management.

Nature communications·2025
Same author

Quantum Dots-Engineered Microlasers with Bidirectional Wavelength Tuning for Single-Cell Biosensing.

ACS nano·2025

Related Experiment Video

Updated: Mar 31, 2026

Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells
10:57

Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells

Published on: October 24, 2019

11.0K

Antigenically Modified Human Pluripotent Stem Cells Generate Antigen-Presenting Dendritic Cells.

Jieming Zeng1, Chunxiao Wu1, Shu Wang1,2

  • 1Institute of Bioengineering and Nanotechnology, Singapore.

Scientific Reports
|October 17, 2015
PubMed
Summary

Researchers developed a simplified method for creating dendritic cell (DC) vaccines using modified human pluripotent stem cells (hPSCs). This novel approach eliminates the need for conventional antigen loading, streamlining DC vaccine production for cancer immunotherapy.

More Related Videos

Generation of Human Monocyte-derived Dendritic Cells from Whole Blood
07:35

Generation of Human Monocyte-derived Dendritic Cells from Whole Blood

Published on: December 24, 2016

21.5K
Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

7.5K

Related Experiment Videos

Last Updated: Mar 31, 2026

Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells
10:57

Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells

Published on: October 24, 2019

11.0K
Generation of Human Monocyte-derived Dendritic Cells from Whole Blood
07:35

Generation of Human Monocyte-derived Dendritic Cells from Whole Blood

Published on: December 24, 2016

21.5K
Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

7.5K

Area of Science:

  • Biotechnology
  • Immunology
  • Stem Cell Biology

Background:

  • Human pluripotent stem cells (hPSCs) are a valuable source for generating dendritic cells (DCs) for vaccine development.
  • Current methods for producing DC vaccines often involve complex antigen-loading steps.
  • Streamlining DC vaccine production is crucial for advancing cancer immunotherapy.

Purpose of the Study:

  • To investigate a novel antigen-loading strategy for DC vaccine production using hPSCs.
  • To simplify the generation of immunocompetent, tumor antigen-presenting DCs from hPSCs.
  • To eliminate the conventional antigen-loading step in hPSC-derived DC vaccine manufacturing.

Main Methods:

  • Stable genetic modification of hPSCs with tumor antigen genes (full-length or minigene).
  • Differentiation of antigenically modified hPSCs into dendritic cells (DCs).
  • Assessment of DC capacity to prime and expand tumor antigen-specific T cells without conventional loading.

Main Results:

  • Antigenically modified hPSCs differentiated into functional tumor antigen-presenting DCs.
  • DCs derived from minigene-modified hPSCs initiated tumor antigen-specific T cell responses.
  • Expanded T cells exhibited potent effector functions and a memory phenotype (central/effector).
  • The strategy successfully eliminated the need for conventional antigen-loading.

Conclusions:

  • Immunocompetent, tumor antigen-loaded DCs can be directly generated from antigenically modified hPSCs.
  • This novel strategy significantly simplifies the production of DC vaccines from hPSCs.
  • The approach holds promise for more efficient development of cancer immunotherapies.